The House Energy and Commerce Committee has substantially trimmed down its “21st Century Cures” reform wish list in an updated legislative proposal posted April 29, but significant device regulatory reforms, including a breakthrough device priority review program, remain in play.
The updated discussion draft is about half the length of the first version issued in January. It was discussed at an April 30 subcommittee hearing that included testimony...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?